Cite
HARVARD Citation
Borowczyk, M. et al. (2015). The JAK2 V617F mutational status and allele burden may be related with the risk of venous thromboembolic events in patients with Philadelphia-negative myeloproliferative neoplasms. Thrombosis research. 135 (2), pp. 272-280. [Online].